These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 11771853)
1. Lipophilic statins can be osteogenic by promoting osteoblastic calcification in a Cbfa1- and BMP-2-independent manner. Izumo N; Fujita T; Nakamuta H; Koida M Methods Find Exp Clin Pharmacol; 2001 Sep; 23(7):389-94. PubMed ID: 11771853 [TBL] [Abstract][Full Text] [Related]
2. Statins inhibit osteoblast migration by inhibiting Rac-Akt signaling. Fukuyama R; Fujita T; Azuma Y; Hirano A; Nakamuta H; Koida M; Komori T Biochem Biophys Res Commun; 2004 Mar; 315(3):636-42. PubMed ID: 14975748 [TBL] [Abstract][Full Text] [Related]
3. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells. Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871 [TBL] [Abstract][Full Text] [Related]
4. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083 [TBL] [Abstract][Full Text] [Related]
5. Incadronate and etidronate accelerate phosphate-primed mineralization of MC4 cells via ERK1/2-Cbfa1 signaling pathway in a Ras-independent manner: further involvement of mevalonate-pathway blockade for incadronate. Fujita T; Izumo N; Fukuyama R; Meguro T; Yasutomi C; Nakamuta H; Koida M Jpn J Pharmacol; 2001 May; 86(1):86-96. PubMed ID: 11430477 [TBL] [Abstract][Full Text] [Related]
6. [The role of mevalonate pathway in osteogenic cells]. Ishimi Y Nihon Rinsho; 2004 Feb; 62 Suppl 2():779-82. PubMed ID: 15035226 [No Abstract] [Full Text] [Related]
7. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action]. Yoneda T Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970 [No Abstract] [Full Text] [Related]
8. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis. Nagashima T; Okazaki H; Yudoh K; Matsuno H; Minota S Arthritis Rheum; 2006 Feb; 54(2):579-86. PubMed ID: 16447234 [TBL] [Abstract][Full Text] [Related]
11. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. Maeda T; Matsunuma A; Kurahashi I; Yanagawa T; Yoshida H; Horiuchi N J Cell Biochem; 2004 Jun; 92(3):458-71. PubMed ID: 15156558 [TBL] [Abstract][Full Text] [Related]
12. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529 [TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828 [TBL] [Abstract][Full Text] [Related]
14. The interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiation. Liu CJ; Chang E; Yu J; Carlson CS; Prazak L; Yu XP; Ding B; Lengyel P; Di Cesare PE J Biol Chem; 2005 Jan; 280(4):2788-96. PubMed ID: 15557274 [TBL] [Abstract][Full Text] [Related]
15. Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells. Ikeda U; Shimpo M; Ohki R; Inaba H; Takahashi M; Yamamoto K; Shimada K Hypertension; 2000 Sep; 36(3):325-9. PubMed ID: 10988259 [TBL] [Abstract][Full Text] [Related]
16. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Maeda T; Kawane T; Horiuchi N Endocrinology; 2003 Feb; 144(2):681-92. PubMed ID: 12538631 [TBL] [Abstract][Full Text] [Related]
17. Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy. Ogata Y; Takahashi M; Takeuchi K; Ueno S; Mano H; Ookawara S; Kobayashi E; Ikeda U; Shimada K J Cardiovasc Pharmacol; 2002 Dec; 40(6):907-15. PubMed ID: 12451324 [TBL] [Abstract][Full Text] [Related]
18. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Sugiyama M; Kodama T; Konishi K; Abe K; Asami S; Oikawa S Biochem Biophys Res Commun; 2000 May; 271(3):688-92. PubMed ID: 10814523 [TBL] [Abstract][Full Text] [Related]
19. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells. Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834 [TBL] [Abstract][Full Text] [Related]
20. Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions. Robinson AJ; Kashanin D; O'Dowd F; Fitzgerald K; Williams V; Walsh GM Clin Exp Allergy; 2009 Dec; 39(12):1866-74. PubMed ID: 19689459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]